(Q44113439)

English

Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure

scientific article published in May 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Francesca Ceccherini-Silberstein

15

object named as

Francesca Ceccherini-Silberstein

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Maria M Santoro

object named as

Maria Mercedes Santoro

7

0 references

object named as

Stefano Alcaro

6

0 references

Andrea Antinori

13

object named as

Andrea Antinori

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Roberta D'Arrigo

3

object named as

Roberta D'Arrigo

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Valentina Svicher

1

object named as

Valentina Svicher

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Zaccarelli Mauro

11

object named as

Mauro Zaccarelli

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Rita Bellagamba

10

object named as

Rita Bellagamba

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Pasquale Narciso

14

object named as

Pasquale Narciso

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Carlo Federico Perno

16

object named as

Carlo-Federico Perno

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Ubaldo Visco-Comandini

12

object named as

Ubaldo Visco-Comandini

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Salvatore Dimonte

5

object named as

Salvatore Dimonte

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

4

object named as

Anna Artese

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

2

object named as

Stefano Aquaro

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

author name string

Giovanni Di Perri

8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sergio Lo Caputo

9

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

language of work or name

0 references

publication date

1 May 2008

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

197

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1408-1418

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

Peptide and non-peptide HIV fusion inhibitors

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

Impact of human immunodeficiency virus type 1 gp41 amino acid substitutions selected during enfuvirtide treatment on gp41 binding and antiviral potency of enfuvirtide in vitro

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

HIV fusion and its inhibition in antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

HIV resistance to the fusion inhibitor enfuvirtide: mechanisms and clinical implications

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

Enfuvirtide resistance mutations: impact on human immunodeficiency virus envelope function, entry inhibitor sensitivity, and virus neutralization

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

Emergence and evolution of enfuvirtide resistance following long-term therapy involves heptad repeat 2 mutations within gp41.

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

Genotypic changes in human immunodeficiency virus type 1 envelope glycoproteins on treatment with the fusion inhibitor enfuvirtide and their influence on changes in drug susceptibility in vitro

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with virologic failure on enfuvirtide

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

Mechanisms of apoptosis induction by the HIV-1 envelope

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

Point mutations in the C-terminus of HIV-1 gp160 reduce apoptosis and calmodulin binding without affecting viral replication

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

Fusion-induced apoptosis contributes to thymocyte depletion by a pathogenic human immunodeficiency virus type 1 envelope in the human thymus

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

Core structure of gp41 from the HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

Structural and functional analysis of interhelical interactions in the human immunodeficiency virus type 1 gp41 envelope glycoprotein by alanine-scanning mutagenesis

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

Different from the HIV fusion inhibitor C34, the anti-HIV drug Fuzeon (T-20) inhibits HIV-1 entry by targeting multiple sites in gp41 and gp120.

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

Specific regulation of mRNA splicing in vitro by a peptide from HIV-1 Rev.

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

Mutations conferring resistance to human immunodeficiency virus type 1 fusion inhibitors are restricted by gp41 and Rev-responsive element functions

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

Determination of RNA structure and thermodynamics

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

The envelope gene is a cytopathic determinant of CCR5 tropic HIV-1.

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

Site-specific Mutations in HIV-1 gp41 Reveal a Correlation between HIV-1-mediated Bystander Apoptosis and Fusion/Hemifusion

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment

1 reference

https://api.crossref.org/works/10.1086%2F587693

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44113439&oldid=2106713590"